Adoptive Immunotherapy of Cancer using Activated Autologous Lymphocytes -Current Status and New Strategies-Yoshiyuki Yamaguchi, Tetsuya Toge, Akiko Ohshita et al.|Human Cell|2003Cited by 32
Feasibility study of adoptive immunotherapy for metastatic lung tumors using peptide-pulsed dendritic cell-activated killer (PDAK) cells.Yoshiyuki Yamaguchi, Tetsuya Toge, Koji Ohta et al.|PubMed|2005Cited by 19
Novel system for generating cytotoxic effector lymphocytes using carcinoembryonic antigen (CEA) peptide and cultured dendritic cells.Koji Ohta, Tetsuya Toge, Yoshiyuki Yamaguchi et al.|PubMed|2003Cited by 13
Generation of Antigen-Presenting Cells Using Cultured Dendritic Cells and Amplified Autologous Tumor mRNAKazuhito Minami, Tetsuya Toge, Yoshiyuki Yamaguchi et al.|Oncology|2005Cited by 5
Generation of cytotoxic effector lymphocytes by MLTC using tumor cells genetically modified to secrete interleukin-2.Yoshiyuki Yamaguchi, Tetsuya Toge, Katsuhiko Shimizu et al.|PubMed|2001Cited by 3